Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021)

Sodium glucose co-transporter 2 (SGLT2) inhibitors are now an established class of medications for the treatment of type 2 diabetes (T2D), no longer reserved for use by specialists in diabetes. They are being used increasingly for their cardiac and renal benefits by primary care, cardiology and rena...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Clin Med (Lond)
Main Authors: Dashora, Umesh, Gregory, Robert, Winocour, Peter, Dhatariya, Ketan, Rowles, Susannah, Macklin, Andrew, Rayman, Gerry, Nagi, Dinesh, Whitehead, Katie, Beba, Hannah, De, Parijat, Patel, Dipesh C
פורמט: Artigo
שפה:Inglês
יצא לאור: Royal College of Physicians 2021
נושאים:
Concise Guidance
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140708/
https://ncbi.nlm.nih.gov/pubmed/34001571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2021-0045
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים